Interestingly, TAM polarization and recruitment into the tumor microenvironment have been associated, not only with poor clinical outcomes in patients with breast tumors [100,104,105], but also with the hampering of anti-HER2-specific agents’ activity [106]. Here, ERBB2 is linked to neoplasm.